Genmab | GEN - DEBITO

Prezzo Delle Azioni
1,713.00
Cambio Giornaliero
-1.50 -0.09%
Mensile
-6.14%
Annuale
23.33%
Q1 Previsione
1,614.31




DEBITO Cambiamento Data
Agios Pharmaceuticals USD 44.52M 4.24M 2025-09
Almirall EUR 342.86M 61.94M 2025-12
Amarin USD 0 0 2025-03
Amgen USD 54.59B 1.62B 2025-09
argenx SE USD 43.15M 4.1M 2025-06
AstraZeneca USD 32.63B 207M 2025-09
Bayer EUR 39.39B 1.31B 2025-03
BioMarin Pharmaceutical USD 604.24M 375K 2025-09
Demant DKK 20.99B 4.81B 2025-12
Exelixis USD 176.46M 3.38M 2025-09
Fresenius Medical Care EUR 10.8B 322.94M 2025-12
Galapagos EUR 7.5M 3.36M 2025-09
Genmab DKK 148M 5M 2025-06
GlaxoSmithKline GBP 17.75B 396M 2025-09
GN Store Nord DKK 11.79B 15M 2025-06
GRIFOLS EUR 8.82B 1.23B 2025-06
Hikma Pharmaceutical USD 1.56B 252M 2025-06
Insmed USD 727.89M 163.33M 2025-12
Lonza CHF 4.71B 915M 2024-12
Merck EUR 12.1B 2.7B 2025-09
Novartis USD 32.64B 1.37B 2025-06
Regeneron Pharmaceuticals USD 2.71B 400K 2025-09
Roche Holding CHF 33.03B 1.41B 2025-06
Sanofi EUR 21.76B 530M 2025-09
UCB EUR 3.03B 12M 2024-12